Board of trustees

The boards of trustees of the individual Fraunhofer Institutes act as purely advisory bodies to their institute’s management. The members come from academia, industry, and government agencies. In 2019, the Fraunhofer ITEM board of trustees was made up of the following members:

Dr. Eckhard von Keutz
Chairman of the board of trustees
Head of Translational Sciences
Bayer AG

Dr. Marcus Beiner
Deputy Head of the Department of Research, Innovation, Europe,
Head of the Division of Europe and International Affairs,
Lower Saxony Ministry of Science and Culture

Prof. Dr. Paul-Georg Germann
Global Head of Chemical and Preclinical Safety (CPS), Merck Healthcare KGaA

Prof. Dr. Wolfgang Herr
Full professor and Head of the Department of Internal Medicine III,
University Hospital Regensburg

Prof. Dr. Edith M. Hessel
Vice President and Head Refractory Respiratory Inflammation Discovery Performance Unit,
GlaxoSmithKline UK

Prof. Dr. Michael Hildebrand
Managing Director, Hildebrand Pharma Consulting

Dr. Sylvia Jacobi
Corporate Toxicology Director,
Albemarle Europe (Belgium)

Prof. Dr. Dieter Jahn
Head of the Institute of Microbiology, Technische Universität Braunschweig,
Spokesman of the Braunschweig Integrated Centre of Systems Biology – BRICS

Dr. Frank Kalkbrenner
Managing Director, Boehringer Ingelheim Corporate Venture Fund

Prof. Prof. h. c. Dr. Thomas Lenarz
Director of the Department of Otorhinolaryngology
and Director of Deutsches HörZentrum,
Hannover Medical School

Ministerialrätin Dr. Evelyn Obele
Head of Division 614 – Health Research, Medical Technology,
German Federal Ministry of Education and Research

Prof. Clive Page, OBE, Ph.D.
Head of Sackler Institute of Pulmonary Pharmacology,
School of Cancer and Pharmaceutical Science,
King’s College London

Prof. Dr. med. Julia Carolin Stingl
Full academic professor in Molecular Pharmacology,
full professor and Director of the Institute of Clinical Pharmacology,
University Hospital Aachen

Dr. Torsten Wagner
Senior Vice President, Corporate Technical Operations,
Merz Pharma GmbH & Co. KGaA

(October 2019)